JOURNAL OF BUON, cilt.18, sa.4, ss.874-878, 2013 (SCI-Expanded)
Purpose: In this study, the antiproliferative effects of the aromatase inhibitor anastrozole (arimidex (R)) was evaluated on estrogen receptor (ER) positive FM3A cell line originated from C3H mouse mammary carcinoma.